Literature DB >> 9261349

The potent enhancer activity of the polycythemic strain of spleen focus-forming virus in hematopoietic cells is governed by a binding site for Sp1 in the upstream control region and by a unique enhancer core motif, creating an exclusive target for PEBP/CBF.

C Baum1, K Itoh, J Meyer, C Laker, Y Ito, W Ostertag.   

Abstract

The polycythemic strain of the spleen focus-forming virus (SFFVp) contains the most potent murine retroviral enhancer configuration known so far for gene expression in myeloerythroid hematopoietic cells. In the present study, we mapped two crucial elements responsible for the high activity of the SFFVp enhancer to an altered upstream control region (UCR) containing a GC-rich motif (5'-GGGCGGG-3') and to a unique enhancer core (5'-TGCGGTC-3'). Acquisition of these motifs accounts for half of the activity of the complete retroviral enhancer in hematopoietic cells, irrespective of the developmental stage or lineage. Furthermore, the UCR motif contains the major determinant for the enhancer activity of SFFVp in embryonic stem (ES) cells. Using electrophoretic mobility shift assays, we show that the UCR of SFFVp, but not of Friend murine leukemia virus, is targeted by the ubiquitous transcriptional activator, Sp1. The core motif of SFFVp creates a specific and high-affinity target for polyomavirus enhancer binding protein/core binding factor (PEBP/CBF) and excludes access of CAAT/enhancer binding protein. Cotransfection experiments with ES cells imply that PEBP/CBF cooperates with the neighboring element, LVb (the only conserved Ets consensus in the SFFVp enhancer), and that the Sp1 motif in the UCR stimulates transactivation through the Ets-PEBP interaction. Putative secondary structures of the retroviral enhancers are proposed based on these data.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9261349      PMCID: PMC191905     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  69 in total

1.  Sequences responsible for the altered erythropoietin responsiveness in spleen focus-forming virus strain SFFVP-infected cells are localized to a 678-base-pair region at the 3' end of the envelope gene.

Authors:  S W Chung; L Wolff; S Ruscetti
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

Review 2.  Transforming genes and target cells of murine spleen focus-forming viruses.

Authors:  W Ostertag; C Stocking; G R Johnson; N Kluge; R Kollek; T Franz; N Hess
Journal:  Adv Cancer Res       Date:  1987       Impact factor: 6.242

3.  Distinct segments within the enhancer region collaborate to specify the type of leukemia induced by nondefective Friend and Moloney viruses.

Authors:  E Golemis; Y Li; T N Fredrickson; J W Hartley; N Hopkins
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

4.  Disease specificity of nondefective Friend and Moloney murine leukemia viruses is controlled by a small number of nucleotides.

Authors:  Y Li; E Golemis; J W Hartley; N Hopkins
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

5.  Subcellular localization of the alpha and beta subunits of the acute myeloid leukemia-linked transcription factor PEBP2/CBF.

Authors:  J Lu; M Maruyama; M Satake; S C Bae; E Ogawa; H Kagoshima; K Shigesada; Y Ito
Journal:  Mol Cell Biol       Date:  1995-03       Impact factor: 4.272

Review 6.  Vintage reds and whites: combinatorial transcription factor utilization in hematopoietic differentiation.

Authors:  S A Ness; J D Engel
Journal:  Curr Opin Genet Dev       Date:  1994-10       Impact factor: 5.578

7.  AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization.

Authors:  D Levanon; V Negreanu; Y Bernstein; I Bar-Am; L Avivi; Y Groner
Journal:  Genomics       Date:  1994-09-15       Impact factor: 5.736

8.  The murine interleukin-3 receptor alpha subunit gene: chromosomal localization, genomic structure, and promoter function.

Authors:  I Miyajima; L Levitt; T Hara; M A Bedell; N G Copeland; N A Jenkins; A Miyajima
Journal:  Blood       Date:  1995-03-01       Impact factor: 22.113

9.  An enhancer sequence instability that diversifies the cell repertoire for expression of a murine leukemia virus.

Authors:  C Spiro; J P Li; R K Bestwick; D Kabat
Journal:  Virology       Date:  1988-06       Impact factor: 3.616

10.  Sp1 sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island.

Authors:  D Macleod; J Charlton; J Mullins; A P Bird
Journal:  Genes Dev       Date:  1994-10-01       Impact factor: 11.361

View more
  14 in total

1.  Complex effects of deletions in the 5' untranslated region of primate foamy virus on viral gene expression and RNA packaging.

Authors:  M Heinkelein; J Thurow; M Dressler; H Imrich; D Neumann-Haefelin; M O McClure; A Rethwilm
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Design of 5' untranslated sequences in retroviral vectors developed for medical use.

Authors:  M Hildinger; K L Abel; W Ostertag; C Baum
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

3.  A ubiquitous chromatin opening element (UCOE) confers resistance to DNA methylation-mediated silencing of lentiviral vectors.

Authors:  Fang Zhang; Amy R Frost; Mike P Blundell; Olivia Bales; Michael N Antoniou; Adrian J Thrasher
Journal:  Mol Ther       Date:  2010-06-29       Impact factor: 11.454

4.  Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectors.

Authors:  Ute Modlich; Susana Navarro; Daniela Zychlinski; Tobias Maetzig; Sabine Knoess; Martijn H Brugman; Axel Schambach; Sabine Charrier; Anne Galy; Adrian J Thrasher; Juan Bueren; Christopher Baum
Journal:  Mol Ther       Date:  2009-08-11       Impact factor: 11.454

5.  Host cis-mediated extinction of a retrovirus permissive for expression in embryonal stem cells during differentiation.

Authors:  C Laker; J Meyer; A Schopen; J Friel; C Heberlein; W Ostertag; C Stocking
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

6.  In vivo analysis of retroviral enhancer mutations in hematopoietic cells: SP1/EGR1 and ETS/GATA motifs contribute to long terminal repeat specificity.

Authors:  Anke Wahlers; Peter F Zipfel; Maike Schwieger; Wolfram Ostertag; Christopher Baum
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

7.  Insertion of myeloid-active elements into the human cytomegalovirus major immediate early promoter is not sufficient to drive its activation upon infection of undifferentiated myeloid cells.

Authors:  Qingsong Qin; Song Hee Lee; Ruibin Liang; Robert F Kalejta
Journal:  Virology       Date:  2013-10-24       Impact factor: 3.616

8.  A protocol describing the genetic correction of somatic human cells and subsequent generation of iPS cells.

Authors:  Angel Raya; Ignasi Rodríguez-Pizà; Susana Navarro; Yvonne Richaud-Patin; Guillermo Guenechea; Adriana Sánchez-Danés; Antonella Consiglio; Juan Bueren; Juan Carlos Izpisúa Belmonte
Journal:  Nat Protoc       Date:  2010-03-11       Impact factor: 13.491

9.  Efficient intracellular retrotransposition of an exogenous primate retrovirus genome.

Authors:  M Heinkelein; T Pietschmann; G Jármy; M Dressler; H Imrich; J Thurow; D Lindemann; M Bock; A Moebes; J Roy; O Herchenröder; A Rethwilm
Journal:  EMBO J       Date:  2000-07-03       Impact factor: 11.598

10.  Characterization of a cis-acting sequence in the Pol region required to transfer human foamy virus vectors.

Authors:  M Heinkelein; M Schmidt; N Fischer; A Moebes; D Lindemann; J Enssle; A Rethwilm
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.